Breast cancer organoid: A short history of innovation in breast cancer treatment
Breast cancer has long been one of the most prevalent and challenging cancers worldwide, demanding constant
Scientific Notes
Breast cancer organoids as alternative to animal models
Breast cancer remains the most frequently diagnosed malignancy in women worldwide and a leading cause of
Adipose Tissue-on-Chip: Perfused Platforms Driving Next-Gen Metabolic Research
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Adipose Tissue Organoids: Protocols, Applications & Current Limitations
Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue
Understanding Adipose Tissue: A Key to Drug Discovery in Metabolic Disorders
What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a
Brown vs White Adipose Tissue: What is at Stake for Pharma
As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue
In Vitro Adipose Tissue Models: Organoids, Organs-on-Chip & Next-Generation Platforms
Modern drug discovery is shifting from “one-size-fits-all” animal models toward new-approach methodologies (NAMs) that capture human-specific
How the adipose tissue microenvironment shapes cancer therapy outcomes
The interplay between adipose tissue and therapeutic efficacy is now recognised as a major determinant of clinical
Are spheroids recapitulating basic physiology of human organs?
Spheroids, as a good universal organ model ? Recent advances in bioengineering of cells, tissue coupled
Multiorgan Microphysiological Systems as Tools to Interrogate Interorgan Crosstalk and Complex Diseases
Introduction MPS (Multiorgan Microphysiological Systems) have evolved from tools to reduce animal experimentation and improve preclinical
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!